Qube Research & Technologies (QRT)
XLRN

Qube Research & Technologies (QRT)’s Acceleron Pharma XLRN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6,000
Closed -$1.03M – 3186
2021
Q3 		$1.03M Buy
+6,000
New +$785K 0.01% 900
2021
Q1 		– Sell
-2,936
Closed -$376K – 2589
2020
Q4 		$376K Buy
+2,936
New +$344K 0.01% 1263
2020
Q3 		– Sell
-29,323
Closed -$2.79M – 2249
2020
Q2 		$2.79M Buy
29,323
+17,859
+156% +$1.72M 0.04% 555
2020
Q1 		$1.03M Buy
+11,464
New +$891K 0.04% 381

Qube Research & Technologies (QRT)'s XLRN Position: Q4 2021 in Review

Qube Research & Technologies (QRT) sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 6,000 shares — an estimated $1.03M sold.

Qube Research & Technologies (QRT) first reported a position in XLRN in Q1 2020 and held it in 4 quarters. The position peaked at $2.79M in Q2 2020. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Qube Research & Technologies (QRT) reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 6,000 Acceleron Pharma shares in Q4 2021, an estimated $1.03M.
  • Qube Research & Technologies (QRT) first reported a position in Acceleron Pharma in Q1 2020 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s Acceleron Pharma position peaked at $2.79M in Q2 2020.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2021, filed 1 Feb 2022.